Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014184)
◆英語タイトル:Centene Corp (CNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014184
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:61
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare products and services including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals), the Supplemental security income program a/k/a the Aged, blind or disabled program (ABD), Medicare and Health Insurance Marketplace. Centene through its Specialty Services companies offers life and health management, behavioral health and specialty rehabilitation therapies, managed vision, long-term care programs, telehealth services and pharmacy benefits management to healthcare organizations, employer groups, state programs and other commercial organizations. The company along with its subsidiaries serves various states across the US. Centene is headquartered in Saint Louis, Missouri, the US.

Centene Corp (CNC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Centene Corp, Medical Devices Deals, 2011 to YTD 2017 9
Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Centene Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Specialty Therapeutic Care Holdings Secures US$18.6 Million In Venture Financing 11
Casenet Secures An Additional US$3.3 Million In Venture Financing 12
Equity Offering 13
Centene Files Registration Statement For Public Offering Of Common Stock For US$15.3 Million 13
Debt Offering 14
Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 14
Centene Completes Public Offering Of Notes Due 2022 For US$300 Million 15
Centene Completes Public Offering Of Notes Due 2017 For US$175 Million 16
Centene Completes Public Offering Of 5.75% Senior Notes Due 2017 For US$250 Million 17
Asset Transactions 19
CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For US$160 Million 19
Acquisition 20
Centene to Acquire Agate Resources 20
Centene Completes Acquisition of Stake in Ribera Salud 21
Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For US$200 Million 22
Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For US$152 Million 23
Specialty Therapeutic Care Acquires ITS Pharmacy 25
Centene Corp – Key Competitors 26
Centene Corp – Key Employees 27
Centene Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 30
Recent Developments 31
Strategy And Business Planning 31
Sep 14, 2016: Centene Expands Marketplace Offering In Arizona 31
Apr 15, 2016: Centene Corporation celebrates grand opening of Ferguson Service Center 32
Financial Announcements 33
Oct 24, 2017: Centene Reports 2017 Third Quarter Results & Updates 2017 Guidance 33
Jul 25, 2017: Centene Reports 2017 Second Quarter Results & Raises 2017 Guidance 35
Apr 25, 2017: Centene Reports 2017 First Quarter Results & Updates 2017 Guidance 37
Feb 07, 2017: Centene Reports 2016 Fourth Quarter And Full Year Results 39
Oct 25, 2016: Centene Reports 2016 Third Quarter Results 41
Jul 26, 2016: Centene Reports 2016 Second Quarter Results 43
Apr 26, 2016: Centene Reports 2016 First Quarter Results & Updates 2016 Guidance 45
Feb 09, 2016: Centene Reports 2015 Fourth Quarter And Full Year Results 47
Jan 26, 2016: Centene Announces Preliminary 2015 Financial Results 49
Corporate Communications 50
Nov 16, 2017: Centene Announces Organizational Enhancements and Several Key Leadership Appointments 50
Apr 28, 2016: Centene Appoints Christopher Isaak As Corporate Controller And Chief Accounting Officer 51
Apr 04, 2016: Centene Appoints Mark Brooks As Chief Information Officer 52
Legal and Regulatory 53
Sep 19, 2017: Coordinated Care Awarded Commendable Accreditation Status From NCQA 53
Nov 14, 2016: GAO Decision Upholds TRICARE West Region Contract Award To Centene Subsidiary 54
Nov 04, 2016: Centene Reaches Settlement With Commonwealth of Kentucky 55
Oct 07, 2016: Centene’s Kansas Subsidiary Awarded Commendable Accreditation Status From NCQA 56
May 13, 2016: Centene’s Florida Subsidiary Awarded Accreditation From NCQA 57
Mar 23, 2016: Centene And Health Net Receive CDI Regulatory Approval 58
Jan 21, 2016: Centene’s Arkansas Subsidiary Awarded Accreditation From NCQA 59
Other Significant Developments 60
Jul 19, 2017: Centene Partners With Schnucks And People’s Health Centers To Open Ferguson Clinic 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Centene Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Centene Corp, Medical Devices Deals, 2011 to YTD 2017 9
Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Specialty Therapeutic Care Holdings Secures US$18.6 Million In Venture Financing 11
Casenet Secures An Additional US$3.3 Million In Venture Financing 12
Centene Files Registration Statement For Public Offering Of Common Stock For US$15.3 Million 13
Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 14
Centene Completes Public Offering Of Notes Due 2022 For US$300 Million 15
Centene Completes Public Offering Of Notes Due 2017 For US$175 Million 16
Centene Completes Public Offering Of 5.75% Senior Notes Due 2017 For US$250 Million 17
CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For US$160 Million 19
Centene to Acquire Agate Resources 20
Centene Completes Acquisition of Stake in Ribera Salud 21
Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For US$200 Million 22
Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For US$152 Million 23
Specialty Therapeutic Care Acquires ITS Pharmacy 25
Centene Corp, Key Competitors 26
Centene Corp, Key Employees 27
Centene Corp, Subsidiaries 28
Centene Corp, Joint Venture 30

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析(Centene Corp (CNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆